Silicon Labs next gen chips: Too little, too late

SLAB Q2 guidance implies upside to Q2

Dexcom Q1: strong growth and positive news

Nordic Semiconductor (Buy, TP: NOK160.00) - Not too bad given tail-end...

While implied guidance for H1 revenues is ~1–4% below our forecast and consensus, the underlying sequential performance is directionally in line with the broader set of peers to have reported to date. We find this growth and gross margin profile solid, given we are at the tail-end of the life of Nordic’s 10-year-old 55nm technology platform. Combined with the arguably unprecedented level of uncertainty for the company’s customers, we find it achieving a ~50% gross margin and accelerated Cellular...

Nordic Semiconductor ASA: 1 director

A director at Nordic Semiconductor ASA bought 20,090 shares at 102.500NOK and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...

Soft Q1 growth from Logitech

14% drop seems like an overreaction

Q1 beat, but muted Q2 guidance

Nordic Semiconductor (Buy, TP: NOK174.00) - Near-term momentum likely ...

While the effects of trade tensions and tariff upheaval remain uncertain, our discussions with industry sources suggest strong, improving order momentum in Q1. Moreover, we expect the recently announced 90-day tariff pause to drive pull-forward of US imports. This has led us to shift our estimates from H2 towards H1. Beyond tariff-induced pull-ins, Dexcom channel replenishment dynamics remain one company-specific source of uncertainty to watch, while we estimate a limited effect. We remain sligh...

Two birds with one (very tiny) stone

Nordic Semiconductor (Buy, TP: NOK174.00) - Still appears set for a pi...

While we see data points suggesting the strong Q4 results and Q1 guidance are probably seeing some tailwinds from pre-emptive demand pull-forward ahead of tariffs and intensifying trade tensions, we believe underlying momentum is materially stronger than we forecast and thus have significantly raised our estimates across the board for 2025–2026. Therefore, while we see some risk to the magnitude of sequential growth in Q2–Q3e not being in line with normal patterns, we continue to expect 2025 to ...

Significantly better than modest growth

Strong Q1 guidance to lift 2025 estimates

Silicon Labs Q4: upside to Q1

Nordic Semiconductor (Buy, TP: NOK145.00) - Perception-reality gap set...

We believe 2025 could be the first – and last – year in the next product/technology cycle before the gap between the group’s reported and fundamental competitiveness versus its peers starts to close and the market shifts from being concerned about loss of market share for its nRF52 series towards optimism for its nRF54 series. However, while the market backdrop and downstream inventory are increasingly looking supportive, we still see ongoing near-term legacy risks related to nRF52 competitivene...

Logitech: 10% growth for relevant segments

IT Norway Q4e: growth at reasonable prices

Low expectations for '25e

Positive news for NOD's healthcare segment

Post-Q3 drop gives buying opportunity in Link and Pexip